MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-23-2026
Integer Holdings Corporation Interest Expense 2011-2026 | ITGR
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Integer Holdings Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -53.2 M | -3.52 M | -975 K | 899 K | 31.6 M | 38.2 M | 52.5 M | 99.3 M | 64 M | 68.3 M | 4.25 M | 11.3 M | - | 18.1 M | 16.9 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 99.3 M | -53.2 M | 24.8 M |
Quarterly Interest Expense Integer Holdings Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.13 M | -3.98 M | -47.9 M | - | -916 K | 127 K | -1.01 M | - | -580 K | -359 K | 17.3 M | - | 10.7 M | 7.77 M | 5.97 M | - | 10.1 M | 7.53 M | 8.53 M | - | 9.37 M | 9.27 M | 10.4 M | - | 12.3 M | 13.6 M | 13.8 M | - | 54.5 M | 15.2 M | 15.6 M | - | 15.8 M | 15.1 M | 28.9 M | - | 27.9 M | 27.9 M | 27.6 M | - | 5.82 M | 1.21 M | 1.12 M | - | 1.05 M | 1.07 M | 1.08 M | - | 1.52 M | 1.44 M | 6.99 M | - | 4.4 M | 4.42 M | 4.36 M | - | 4.12 M | 4.4 M | 4.27 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 54.5 M | -47.9 M | 7.92 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
10.1 K | $ 2.23 | 0.52 % | $ 3.48 M |  USA |
 |
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-274 K | $ 10.41 | -0.41 % | $ 1.41 B | USA |
 |
ClearPoint Neuro
CLPT
|
-146 K | $ 9.43 | -15.49 % | $ 267 M | USA |
 |
Alphatec Holdings
ATEC
|
45.9 M | $ 13.01 | -0.34 % | $ 1.95 B | USA |
 |
EDAP TMS S.A.
EDAP
|
232 K | $ 4.05 | 0.02 % | $ 151 M |  France |
 |
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 8.28 | -0.96 % | $ 594 M |  Israel |
 |
Establishment Labs Holdings
ESTA
|
5.82 M | $ 64.65 | -0.55 % | $ 1.91 B |  Costa-rica |
 |
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | USA |
 |
Butterfly Network
BFLY
|
-13 K | $ 4.16 | -2.58 % | $ 881 M | USA |
 |
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | USA |
 |
Boston Scientific Corporation
BSX
|
349 M | $ 70.72 | -0.67 % | $ 105 B | USA |
 |
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | USA |
 |
CONMED Corporation
CNMD
|
31.1 M | $ 37.25 | -0.24 % | $ 1.16 B | USA |
 |
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | USA |
 |
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 16.91 | -1.77 % | $ 397 M | USA |
 |
Neovasc
NVCN
|
133 K | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
347 K | $ 18.43 | -0.11 % | $ 121 M | USA |
 |
Abbott Laboratories
ABT
|
548 M | $ 109.71 | -0.9 % | $ 191 B | USA |
 |
Delcath Systems
DCTH
|
-70 K | $ 9.59 | -1.54 % | $ 344 M | USA |
 |
Bio-Rad Laboratories
BIO
|
48.9 M | $ 268.09 | -0.52 % | $ 7.56 B | USA |
 |
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.1 | -3.46 % | $ 1.28 M | USA |
 |
AxoGen
AXGN
|
167 K | $ 32.26 | -1.51 % | $ 1.49 B | USA |
 |
Align Technology
ALGN
|
7.68 M | $ 172.39 | -2.12 % | $ 12.9 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 8.78 | -3.52 % | $ 676 M | USA |
 |
Bruker Corporation
BRKR
|
-38.2 M | $ 33.42 | -0.95 % | $ 4.98 K | USA |
 |
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.9 | 4.28 % | $ 160 M | USA |
 |
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | USA |
 |
Accuray Incorporated
ARAY
|
559 K | $ 0.37 | -4.45 % | $ 38 M | USA |
 |
IRadimed Corporation
IRMD
|
164 K | $ 103.06 | 0.25 % | $ 1.31 B | USA |